MicroPulse TLT - UK Study

NCT05593354 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-03-28

No results posted yet for this study

Summary

This Prospective Interventional Study will assess the efficacy of MPTLT in the UK.

Conditions

  • Glaucoma
  • Glaucoma Eye
  • Glaucoma, Open-Angle
  • Glaucoma Secondary
  • Glaucoma, Angle-Closure
  • Glaucoma, Neovascular
  • Glaucoma Traumatic
  • Glaucoma Uveitic

Interventions

DEVICE

Micropulse Transscleral laser therapy

Transscleral laser cyclophotocoagulation using the IRIDEX Cyclo G6 machine

Sponsors & Collaborators

  • IRIDEX Corporation

    collaborator UNKNOWN
  • Imperial College Healthcare NHS Trust

    lead OTHER

Principal Investigators

  • Philip A Bloom, MB ChB FRCOphth · Imperial College Healthcare NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05593354 on ClinicalTrials.gov